CJC no dac / IPA
CJC-1295 (No DAC) / Ipamorelin Blend (Research Peptide)
For Research Use Only – Not for Human Consumption, Diagnostic, or Therapeutic Use.
This dual-peptide blend is supplied strictly for laboratory and scientific research applications, such as in vitro and in vivo studies on growth hormone (GH) secretion, IGF-1 modulation, body composition, recovery, and metabolic regulation. All information below is for educational and research reference only.
What Is the CJC-1295 (No DAC) / Ipamorelin Blend?
This is a synergistic research blend combining two complementary growth hormone secretagogues:
CJC-1295 (No DAC) – A short-acting GHRH analogue that stimulates natural, pulsatile GH release.
Ipamorelin – A selective ghrelin mimetic (GHS) that triggers clean GH pulses with minimal impact on cortisol or prolactin.
Typical Research Formulation: Commonly offered as 5 mg + 5 mg or 10mg + 10mg
Supplied as a lyophilized powder for reconstitution in research settings.
Mechanism of Action (Research Context)
In laboratory models, the two peptides work through complementary pathways:
CJC-1295 (No DAC) binds GHRH receptors on pituitary somatotrophs, promoting physiological GH pulses.
Ipamorelin activates the ghrelin receptor (GHSR-1a), further amplifying GH release with high selectivity.
Together they are studied for enhanced, synergistic GH/IGF-1 elevation that more closely mimics natural pulsatile secretion than either peptide alone.
Key Research Areas
Preclinical models commonly explore this blend for:
Increased pulsatile GH and IGF-1 levels
Support for lean body mass and fat metabolism
Improved recovery and tissue repair markers
Sleep quality and metabolic regulation studies
Research Considerations
Typically studied via subcutaneous administration in animal models (often multiple times daily due to the short half-life of both peptides). Researchers monitor GH/IGF-1 pulses, body composition, and metabolic endpoints.
Storage for Research: Lyophilized powder is stable at –20°C. Reconstituted solutions should follow standard peptide handling protocols.
Why Researchers Choose This Blend
The CJC-1295 (No DAC) + Ipamorelin combination is one of the most popular research stacks for studying optimized, physiological GH release. It offers a balanced approach that pairs GHRH receptor activation with selective ghrelin receptor stimulation.
Questions about specifications, ratios, COA, or research applications? Contact our support team.
All products are for research purposes only. Not intended for human use.
